Signaturefd, LLC Rapt Therapeutics, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$16.34 - $24.66 $964 - $1,454	-59 Reduced 64.13%	33 $0
Q2 2023 Aug 01, 2023	BUY	$16.06 - $21.61 $947 - $1,274	59 Added 178.79%	92 $1,000
Q2 2022 Aug 10, 2022	BUY	$10.26 - $23.59 $338 - $778	33 New	33 $1,000
Q4 2021 Jan 25, 2022	SELL	$29.5 - $39.5 $855 - $1,145	-29 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$29.86 - $39.47 $865 - $1,144	29 New	29 $1,000

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.